Skip to main content

WPI 2235 Pill - black & yellow capsule/oblong, 22mm

Pill with imprint WPI 2235 is Black & Yellow, Capsule/Oblong and has been identified as Tetracycline Hydrochloride 500 mg. It is supplied by Watson Pharmaceuticals, Inc.

Tetracycline is used in the treatment of Bacterial Infection; Bladder Infection; Acne; Bronchitis; Nongonococcal Urethritis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2235

Tetracycline hydrochloride 500 mg WPI 2235

Tetracycline Hydrochloride

WPI 2235
500 mg
Black & Yellow
22.00 mm
Prescription only
Drug Class
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-2235 (Discontinued)
Inactive Ingredients
lactose, magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, gelatin, titanium dioxide, benzyl alcohol, butylparaben, edetate calcium disodium, FD&C Yellow No. 6, methylparaben, propylparaben, silicon dioxide, sodium propionate, dimethicone, water, alcohol, ethylene glycol monoethyl ether, shellac, soya lecithin

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related images for "WPI 2235"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.